PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in …
Industry Peers
Medical Care Facilities| Headline | Source | Time |
|---|---|---|
This week | ||
 Amid Legal Risks, This Company Is Still Rated a Buy PACS Group shares have rebounded after a Medicare billing scandal, with strong Q2 earnings and Buy ratings, though DOJ and SEC investigations and shareholder lawsuits remain unresolved. | ||
Older | ||
 PACS Group (PACS) Is Down 8.3% After Raising 2026 Revenue Guidance And Holding Buybacks Steady In early August 2026, PACS Group, Inc. reported second-quarter results showing revenue of US$1,428 million and net income of US$76.37 million, and raised its full-year 2026 revenue guidance to a range of US$5.75 billion to US$5.85 billion from US$5.65 billion to US$5.75 billion. Despite authorizing a buyback earlier in the year, PACS Group did not repurchase any shares through June 30, 2026, suggesting management is currently prioritizing operating growth and earnings performance over... | ||
 Wall Street Analysts See a 25.73% Upside in PACS Group, Inc. (PACS): Can the Stock Really Move This High? The consensus price target hints at a 25.7% upside potential for PACS Group, Inc. (PACS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. | ||
 PACS (PACS) Q2 2026 Earnings Call Transcript Net income surged 49.8% while adjusted EBITDA margin expanded 150 basis points. | ||
 Biodesix, Inc. (BDSX) Hit a 52 Week High, Can the Run Continue? Biodesix (BDSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. | ||
 PACS Group Q2 Earnings Call Highlights PACS Group (NYSE:PACS) reported second-quarter 2026 revenue growth of 9.1% and adjusted EBITDA growth of 25% from a year earlier, citing higher occupancy, improved skilled nursing patient mix and continued progress across acquired facilities as they mature within its operating model. Revenue for th | ||
PACS Group Inc (PACS) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ... PACS Group Inc (PACS) reports a 9.1% revenue increase and raises full-year guidance, driven by robust same-store growth and strategic acquisitions. | ||
 PACS Group, Inc. Q2 2026 Earnings Call Summary Moby summary of PACS Group, Inc.'s Q2 2026 earnings call | ||
 PACS Group, Inc. (PACS) Surpasses Q2 Earnings and Revenue Estimates PACS Group, Inc. (PACS) delivered earnings and revenue surprises of +14.55% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 PACS or ALHC: Which Is the Better Value Stock Right Now? PACS vs. ALHC: Which Stock Is the Better Value Option? | ||
 PACS or ALHC: Which Is the Better Value Stock Right Now? PACS vs. ALHC: Which Stock Is the Better Value Option? | ||
 Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. | ||